Source: MarketScreener

Achillion: Achillion Pharmaceuticals : Ahold Delhaize share buyback update June 23, 2020

(marketscreener.com) Zaandam, the Netherlands, June 23, 2020 - Ahold Delhaize has repurchased 250,000 of Ahold Delhaize common shares in the period from June 15, 2020 up to and including June 19, 2020. The shares were repurchased at an average price of €23.60 per share for a total consideration of €5.9 million. These repurchases were made as...https://www.marketscreener.com/ACHILLION-PHARMACEUTICALS-35614/news/Achillion-Pharmaceuticals-Ahold-Delhaize-share-buyback-update-June-23-2020-30809206/?utm_medium=RSS&utm_content=20200623

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Joseph Truitt's photo - President & CEO of Achillion Pharmaceuticals Inc

President & CEO

Joseph Truitt

CEO Approval Rating

87/100

Read more